Pharmaceutico- analytical study of tamra sindura and itsClinical efficacy in the management of kitibha kushta (psoriasis) - nil

Dr B Bhaskara Rao0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年7月22日

试验速览

暂无简介。

•1.Known cases of Psoriasis, without psoriatic arthropathy Exhibiting psoriatic triad – Bright pink or red lesions with pronounced edges, covered with silvery white scales, the scales can be easily separated from the lesion Under the scales there appears a pinkish moist tender skin With the scarping of the moist skin there appear tiny blood droplets (Auspitz’s sign)
•2.Patients suffering from mild to moderate Psoriasis with less than 50 % of the body surface involvement
•3.Patients having less than 10 years duration
•4.Positive histo - pathological finding.(Skin-biopsy - optional)

•1.Age below 18 years and above 60 years
•2.Patients with other forms of Psoriasis like Guttate/ Pustular/ Erythrodermic/ inverse.
•3.Patients suffering from severe Psoriasis with more than 50% of the body surface involvement
•4.Patients having chronic disease i.e. more than10 years duration
•5.Patients who cannot report in person every 2 weeks in the OPD
•6.Patients with poorly controlled Hypertension ( >160/100 mmHg)
•7.Patients with poorly controlled Diabetes Mellitus having Hb A1C of > 7.5%
•8.Patients on medication with corticosteroids, phototherapy, biologics, antidepressants any other drugs that may have an influence on the outcome of the study.
•9.Patients who have a past history of Atrial Fibrillation, Acute Coronary Syndrome, Myocardial Infarction, Stroke or Severe Arrhythmia in the last 6 months.
•10.Symptomatic patient with clinical evidence of Heart failure.
•11.Known HIV positive cases

发起方

Dr B Bhaskara Rao